AI-generated summary
The authors describe a laser micro-irradiation assay adapted to measure DNA repair at double-strand break sites in suspension blood cells, including normal mononuclear cells, leukemia and lymphoma cell lines, and primary patient samples. They report that global changes in H3K27me3 modulated by drug inhibitors did not reflect the dynamic H3K27me3 changes at break sites during repair. The authors state the assay is effective for assessing drug efficacy in suspension hematological cancer cells, based on mechanistic studies and proof-of-principle data.
- Who or what was studied
- Normal mononuclear cells, leukemia and lymphoma cell lines, and primary patient samples (suspension hematological cells)
- Limits stated in the abstract
- The abstract describes a cell-based assay with proof-of-principle patient data only, and does not report a patient sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.